Blaithin Mcmahon to Biomarkers
This is a "connection" page, showing publications Blaithin Mcmahon has written about Biomarkers.
Connection Strength
0.491
-
Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study. Am J Nephrol. 2019; 50(1):19-28.
Score: 0.112
-
Have biomarkers failed in acute kidney injury? No. Intensive Care Med. 2017 06; 43(6):887-889.
Score: 0.097
-
Risk Stratification for Acute Kidney Injury: Are Biomarkers Enough? Adv Chronic Kidney Dis. 2016 05; 23(3):167-78.
Score: 0.090
-
Urinary glutathione S-transferases in the pathogenesis and diagnostic evaluation of acute kidney injury following cardiac surgery: a critical review. Curr Opin Crit Care. 2010 Dec; 16(6):550-5.
Score: 0.062
-
Urinary liver fatty acid-binding protein: another novel biomarker of acute kidney injury. Kidney Int. 2010 Apr; 77(8):657-9.
Score: 0.059
-
Urinary biomarkers predict progression and adverse outcomes of acute kidney injury in critical illness. Nephrol Dial Transplant. 2022 08 22; 37(9):1668-1678.
Score: 0.035
-
Subphenotypes in acute kidney injury: a narrative review. Crit Care. 2022 08 19; 26(1):251.
Score: 0.035